Maci 3CM x 5CM implant sheets
Ended Awarded Last action
- Contract number
- SPE2DR26FQWH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,176
Award facts
- Contract value 100% obligated
- $63,175.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $63,175.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. This delivery order, issued on December 19, 2025, with an ultimate completion date of January 13, 2026, carries no set-aside designation and was awarded competitively. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a critical supplier within the DOD pharmaceutical supply chain, with recent delivery order activity spanning October through December 2025. The company's established product portfolio encompasses a broad range of pharmaceuticals and specialty surgical products, including MACI implants, supporting recurring medical supply needs of military healthcare facilities. The PPV-G GEN V contract under which this delivery order was issued has a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting DOD military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FQWH1?
SPE2DR26FQWH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FQWH1 worth?
The government has obligated $63,176 on SPE2DR26FQWH1.
Is contract SPE2DR26FQWH1 an order under another contract?
Yes. SPE2DR26FQWH1 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWH1 competed?
The extent of competition for SPE2DR26FQWH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award